A detailed history of Franklin Resources Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Franklin Resources Inc holds 120,006 shares of ALKS stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120,006
Previous 117,103 2.48%
Holding current value
$3.35 Million
Previous $2.82 Million 18.99%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.01 - $28.55 $66,798 - $82,880
2,903 Added 2.48%
120,006 $3.36 Million
Q2 2024

Aug 14, 2024

SELL
$23.21 - $27.24 $2.54 Million - $2.98 Million
-109,489 Reduced 48.32%
117,103 $2.82 Million
Q1 2024

May 13, 2024

BUY
$26.4 - $32.56 $2.16 Million - $2.67 Million
81,852 Added 56.55%
226,592 $6.13 Million
Q4 2023

Feb 09, 2024

SELL
$23.37 - $28.68 $316,196 - $388,040
-13,530 Reduced 8.55%
144,740 $4.02 Million
Q3 2023

Nov 13, 2023

SELL
$27.17 - $31.97 $277,106 - $326,062
-10,199 Reduced 6.05%
158,270 $4.43 Million
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $2.31 Million - $2.74 Million
81,391 Added 93.47%
168,469 $5.27 Million
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $3,315 - $3,801
131 Added 0.15%
87,078 $2.45 Million
Q4 2022

Feb 10, 2023

BUY
$21.94 - $26.24 $11,935 - $14,274
544 Added 0.63%
86,947 $2.27 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $1.14 Million - $1.65 Million
51,758 Added 149.4%
86,403 $1.93 Million
Q2 2022

Aug 11, 2022

SELL
$26.4 - $30.54 $204,362 - $236,410
-7,741 Reduced 18.26%
34,645 $1.03 Million
Q1 2022

May 13, 2022

BUY
$23.07 - $27.99 $160,359 - $194,558
6,951 Added 19.62%
42,386 $1.12 Million
Q4 2021

Feb 11, 2022

BUY
$21.47 - $32.08 $112,030 - $167,393
5,218 Added 17.27%
35,435 $824,000
Q3 2021

Nov 12, 2021

BUY
$23.37 - $32.13 $706,171 - $970,872
30,217 New
30,217 $932,000
Q3 2019

Nov 14, 2019

SELL
$19.51 - $24.28 $50.8 Million - $63.3 Million
-2,605,710 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$21.47 - $37.33 $44.8 Million - $77.9 Million
-2,087,278 Reduced 44.48%
2,605,710 $58.7 Million
Q1 2019

May 14, 2019

BUY
$28.4 - $36.49 $8.72 Million - $11.2 Million
306,988 Added 7.0%
4,692,988 $171 Million
Q4 2018

Feb 12, 2019

BUY
$27.94 - $44.61 $3.36 Million - $5.36 Million
120,200 Added 2.82%
4,386,000 $129 Million
Q3 2018

Nov 13, 2018

BUY
$38.6 - $46.12 $7.96 Million - $9.51 Million
206,300 Added 5.08%
4,265,800 $181 Million
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $42.6 Million - $53.9 Million
1,050,170 Added 34.9%
4,059,500 $167 Million
Q1 2018

May 10, 2018

SELL
$53.61 - $67.26 $7.47 Million - $9.37 Million
-139,270 Reduced 4.42%
3,009,330 $174 Million
Q4 2017

Feb 14, 2018

SELL
$47.69 - $55.39 $1.59 Million - $1.84 Million
-33,300 Reduced 1.05%
3,148,600 $172 Million
Q3 2017

Nov 13, 2017

BUY
$49.16 - $54.45 $156 Million - $173 Million
3,181,900
3,181,900 $162 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.58B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.